Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence after Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 TrialRobert J. Motzer,Axel Bex,Paul Russo,Yoshihiko Tomita,Hernan Javier Cutuli,Carlos Rojas,Marine Gross-Goupil,Giovanni Schinzari,Bohuslav Melichar,Philippe Barthelemy, Abraham Ruiz Garcia,Jeffrey Sosman,Marc-Oliver Grimm,Jeffrey C. Goh,Cristina Suarez,Christian K. Kollmannsberger,Suresh G. Nair,Brian M. Shuch,Jian Huang,Burcin Simsek,Julia Spiridigliozzi,Chung-Wei Lee,Maximiliano van Kooten Losio,Viktor GruenwaldJOURNAL OF CLINICAL ONCOLOGY（2025）引用 0|浏览5AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
